CL2019002640A1 - Moléculas propioticas para reducir virulencia de patógenos. - Google Patents

Moléculas propioticas para reducir virulencia de patógenos.

Info

Publication number
CL2019002640A1
CL2019002640A1 CL2019002640A CL2019002640A CL2019002640A1 CL 2019002640 A1 CL2019002640 A1 CL 2019002640A1 CL 2019002640 A CL2019002640 A CL 2019002640A CL 2019002640 A CL2019002640 A CL 2019002640A CL 2019002640 A1 CL2019002640 A1 CL 2019002640A1
Authority
CL
Chile
Prior art keywords
pathogens
reduce virulence
virulence
proprietary
molecules
Prior art date
Application number
CL2019002640A
Other languages
English (en)
Inventor
Monica Angela Cella
Sarah M Curtis
Jonathon Patrick Roepke
Original Assignee
Microsintesis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microsintesis Inc filed Critical Microsintesis Inc
Publication of CL2019002640A1 publication Critical patent/CL2019002640A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/195—Proteins from microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE PROPORCIONAN PÉPTIDOS DERIVADOS DE BACTERIAS PROBIÓTICAS QUE SE UTILIZAN PARA PREVENIR Y/O TRATAR INFECCIONES NO ENTÉRICAS EN UN SUJETO. LOS PÉPTIDOS DERIVADOS DE LAS BACTERIAS PROBIÓTICAS TAMBIÉN TIENEN USO PARA REDUCIR LA VIRULENCIA DE LAS INFECCIONES NO ENTÉRICAS EN UN SUJETO. TAMBIÉN SE PROPORCIONAN COMPOSICIONES DE LOS PÉPTIDOS FORMULADOS COMO O DENTRO DE PRODUCTOS ALIMENTICIOS, BEBIDAS, SUPLEMENTOS NUTRICIONALES, MEDICAMENTOS Y SIMILARES.
CL2019002640A 2017-03-16 2019-09-16 Moléculas propioticas para reducir virulencia de patógenos. CL2019002640A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762472061P 2017-03-16 2017-03-16

Publications (1)

Publication Number Publication Date
CL2019002640A1 true CL2019002640A1 (es) 2020-05-15

Family

ID=63521745

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019002640A CL2019002640A1 (es) 2017-03-16 2019-09-16 Moléculas propioticas para reducir virulencia de patógenos.

Country Status (16)

Country Link
US (2) US11912788B2 (es)
EP (1) EP3595698A4 (es)
JP (2) JP2020510096A (es)
KR (2) KR20190140443A (es)
CN (1) CN110621332A (es)
AU (2) AU2018233183A1 (es)
BR (1) BR112019019256A2 (es)
CA (1) CA3056719A1 (es)
CL (1) CL2019002640A1 (es)
EA (1) EA201992176A1 (es)
MA (1) MA51873A (es)
MX (1) MX2019011058A (es)
PE (1) PE20191783A1 (es)
PH (1) PH12019502340A1 (es)
SG (1) SG11201909606RA (es)
WO (1) WO2018165765A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA52150A (fr) * 2017-03-16 2020-01-22 Microsintesis Inc Compositions et procédés faisant intervenir des molécules probiotiques
SG11201909606RA (en) 2017-03-16 2019-11-28 Microsintesis Inc Probiotic molecules for reducing pathogen virulence
CA3145739A1 (en) * 2019-07-02 2021-01-07 Microsintesis Inc. Quorum-sensing inhibitors and/or postbiotic metabolites and related methods
CN113080461A (zh) * 2021-05-14 2021-07-09 艾兰得生物科技研究泰州有限公司 一种具有抑制奇异变形杆菌生长作用的益生菌及其发酵液和应用
CA3150903A1 (en) * 2021-05-14 2022-11-14 Xuejun Li Probiotic for inhibiting growth of proteus mirabilis, and fermentation broth and application thereof
KR102337951B1 (ko) * 2021-06-25 2021-12-13 주식회사 비피도 요로감염 개선, 예방 또는 치료를 위한 락토바실러스 헬베티쿠스 gut10 균주 및 이를 포함하는 조성물
KR102356423B1 (ko) * 2021-07-02 2022-02-09 (주)에스디생명공학 항균, 피부 보습, 항아토피, 피부 장벽 강화, 및 주름 개선 활성을 갖는 복합 균주를 유효성분으로 포함하는 조성물
KR102618322B1 (ko) * 2021-10-08 2023-12-27 순천향대학교 산학협력단 신규한 락토 바실러스 균주, 및 이를 포함하는 결핵 예방, 치료, 또는 개선용 조성물
CN114106096A (zh) * 2021-11-16 2022-03-01 华南理工大学 一种具有改善睡眠活性的六肽及其应用
CN114591879B (zh) * 2022-05-11 2022-12-06 中国农业大学 一种抑制幽门螺杆菌的发酵乳杆菌及其应用
KR102551065B1 (ko) * 2022-05-12 2023-07-03 중앙대학교 산학협력단 김치로부터 유래된 LAB(lactic acid bacteria)을 유효성분으로 포함하는 항-바이오필름 조성물
CN116478882A (zh) * 2023-05-05 2023-07-25 石河子大学 能够提高绵羊日增重和饲料转化率的产酸的混合菌制剂的制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0395309B1 (en) 1989-04-28 1995-12-27 Takara Shuzo Co. Ltd. Human calpastatin-like polypeptide
FR2686085B1 (fr) 1992-01-10 1995-08-04 Agronomique Inst Nat Rech Peptides representant des fragments du cmp, anticorps diriges contre lesdits peptides, et leurs utilisations.
WO1994018832A1 (en) 1993-02-26 1994-09-01 Dana-Farber Cancer Institute, Inc. Cd4 mediated modulation of lipid kinases
US7393663B2 (en) 1997-08-01 2008-07-01 Serono Genetics Institute S.A. Expressed sequence tags and encoded human proteins
US20040031072A1 (en) 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
WO2004092206A1 (ja) 2003-04-14 2004-10-28 Meiji Dairies Corporation 新規ペプチドおよび免疫賦活剤、機能性食品ならびに機能性食品の製造方法
DE10317870A1 (de) * 2003-04-17 2004-11-04 Crompton Vinyl Additives Gmbh Neues Stabilisatorsystem zur Stabilisierung von halogenhaltigen Polymeren
CN101001635A (zh) * 2003-12-04 2007-07-18 生物膜策略公司 预防生物膜形成、减少现有生物膜和减少细菌群的方法和组合物
US7306677B2 (en) * 2004-01-30 2007-12-11 Boston Scientific Corporation Clamping fixture for coating stents, system using the fixture, and method of using the fixture
US8273710B2 (en) 2004-12-23 2012-09-25 Campina Nederland Holding B.V. Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use
EP1951745A2 (en) * 2005-11-21 2008-08-06 Teagasc Dairy Products Research Centre Casein-derived antimicrobial peptides and lactobacillus strains that produce them
US8431528B2 (en) 2008-05-16 2013-04-30 University Of Maryland, Baltimore Antibacterial Lactobacillus GG peptides and methods of use
US20110262400A1 (en) * 2008-06-27 2011-10-27 University Of Guelph Probiotic bacterial molecules and their use in methods to treat/prevent infection by harmful bacteria and to provide nutritional health
WO2011119484A1 (en) 2010-03-23 2011-09-29 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
PT105073A (pt) 2010-04-26 2011-10-26 Consejo Superior Investigacion Processo de obtenção de extractos peptídicos bioactivos através da hidrólise de proteínas de soro de leite com enzimas de cynara cardunculus, referidos extractos e respectivas utilizações
WO2014020209A1 (es) 2012-07-30 2014-02-06 Consejo Superior De Investigaciones Científicas (Csic) Uso de hidrolizados de proteínas lácteas como protectores a nivel gastrointestinal
WO2014035345A1 (en) 2012-08-29 2014-03-06 Agency For Science, Technology And Research Peptides and uses thereof
EP2890706A1 (en) 2012-08-31 2015-07-08 Westfälische Wilhelms-Universität Münster Methods and peptides for preventing and treating a bcr-abl and a c-abl associated disease
WO2015021530A1 (en) 2013-08-12 2015-02-19 Mansel Griffiths Antiviral methods and compositions comprising probiotic bacterial molecules
CA2928905A1 (en) 2013-10-31 2015-05-07 Hutchison Biofilm Medical Solutions Limited Use of peptides in antibiotic resistance
CN108513593A (zh) 2015-04-23 2018-09-07 南托米克斯有限责任公司 癌症新表位
SG11201909606RA (en) 2017-03-16 2019-11-28 Microsintesis Inc Probiotic molecules for reducing pathogen virulence
MA52150A (fr) 2017-03-16 2020-01-22 Microsintesis Inc Compositions et procédés faisant intervenir des molécules probiotiques

Also Published As

Publication number Publication date
BR112019019256A2 (pt) 2020-04-14
SG11201909606RA (en) 2019-11-28
WO2018165765A1 (en) 2018-09-20
PH12019502340A1 (en) 2020-10-19
CA3056719A1 (en) 2018-09-20
KR20240046640A (ko) 2024-04-09
AU2018233183A1 (en) 2019-10-31
AU2022203650A1 (en) 2022-06-16
EP3595698A1 (en) 2020-01-22
JP2023036938A (ja) 2023-03-14
US20200017547A1 (en) 2020-01-16
EP3595698A4 (en) 2020-12-23
EA201992176A1 (ru) 2020-03-04
US20240150399A1 (en) 2024-05-09
MX2019011058A (es) 2019-12-09
AU2022203650B2 (en) 2024-04-11
WO2018165765A9 (en) 2018-11-22
JP2020510096A (ja) 2020-04-02
CN110621332A (zh) 2019-12-27
US11912788B2 (en) 2024-02-27
PE20191783A1 (es) 2019-12-24
MA51873A (fr) 2020-01-22
KR20190140443A (ko) 2019-12-19

Similar Documents

Publication Publication Date Title
CL2019002640A1 (es) Moléculas propioticas para reducir virulencia de patógenos.
AR110684A1 (es) Composiciones que comprenden cepas bacterianas y método de tratamiento
MX2022012374A (es) Composiciones multi-suplementos.
AR103260A1 (es) Modulación inmunitaria
MX2017009589A (es) Preparaciones terapeuticas de glicanos y metodos relacionados con estas.
MX2015012379A (es) Novedosas cepas de lactobacillus y los usos de las mismas.
CL2016002955A1 (es) Composicion de edulcorante que comprende alulosa y un extracto de stevia; producto alimenticio o bebida que comprende la composicion edulcorante; edulcorante de mesa; uso de la composición edulcorante.
BR112018003745A2 (pt) composições que compreendem um composto de urolitina
AR106644A1 (es) Composiciones nutricionales sinergísticas y usos de las mismas
MX2016012835A (es) Composiciones y metodos para tratar las espinillas.
BR112017026241A2 (pt) composições farmacêuticas e alimentícias para induzir a saciação e prolongar a saciedade em indivíduos que necessitem das mesmas
BR112018003780A2 (pt) composições que compreendem um composto de urolitina
AR102085A1 (es) Composición nutricional para el entorno gastrointestinal para la provisión de un perfil metabólico y microbioma mejorados
CO2018010937A2 (es) Sistemas de formulación para glicolípidos antimicrobianos
CL2020001975A1 (es) Composiciones y metodos de uso de cepas novedosas de lactobacillus fermentum. (divisional solicitud 201801680)
CO2018004582A2 (es) Alimentos para aves y, en particular, alimentos para aves de corral, que comprenden derivados sintéticos de capsaicinoides y dichos alimentos para el uso prohiláctico o el tratamiento de la infección por salmonela
CL2017001818A1 (es) Bacteria de ácido láctico y su uso para el tratamiento de mastitis
SG10201908193PA (en) Nucleotide composition and application in food thereof
MA40645A (fr) Préparation prébiotique à base d'inuline
SG10201808326QA (en) Nutrition composition
MX2018007737A (es) Suplementos masticables de fruta.
MX2020001501A (es) Streptococcus australis como bioterapeuticos.
PH12018500164A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
CL2018000344A1 (es) Composición que comprende compuestos de modulación del gusto, su uso y productos alimenticios que los contienen
MX2018001924A (es) Composiciones nutritivas sinteticas adaptadas para infantes de edades especificas, y sistemas nutritivos que las comprenden.